Gianluca G Ianiro (Gianluca Ianiro, Gianluca Laniro, G Ianiro)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 66

Top Topics

Systematic Review

Irritable Bowel Syndrome

Helicobacter Pylori

Top Venues

Alimentary pharmacology & therapeutics

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut (2024)
Giulia Catassi, Marina Aloi, Valentina Giorgio, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. Nutrients 16 (3) (2024)
Ege Tohumcu, Francesco Kaitsas, Ludovica Bricca, Alessandro Ruggeri, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
Helicobacter pylori and the Human Gastrointestinal Microbiota: A Multifaceted Relationship. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy (2024)
Ege Tohumcu, Francesco Kaitsas, Ludovica Bricca, Alessandro Ruggeri, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
Helicobacter pylori and the Human Gastrointestinal Microbiota: A Multifaceted Relationship. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Giulia Catassi, Marina Aloi, Valentina Giorgio, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. Nutrients 16 (3) (2024)
Giulia Catassi, Marina Aloi, Valentina Giorgio, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. Nutrients 16 (3) (2024)
Lucia Boccabella, Elena Gialluca Palma, Ludovico Montebianco Abenavoli, Giuseppe Guido Maria Scarlata, Mariavirginia Boni, Gianluca G Ianiro, Pierangelo Santori, Jan F Tack, Emidio Scarpellini
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Giulia Catassi, Marina Aloi, Valentina Giorgio, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. Nutrients 16 (3) (2024)
Giovanni Cammarota, Gianluca G Ianiro
A greener gastroenterology: challenges and opportunities for an eco-sustainable approach to digestive diseases. Nature reviews. Gastroenterology & hepatology (2024)
Lucia Boccabella, Elena Gialluca Palma, Ludovico Montebianco Abenavoli, Giuseppe Guido Maria Scarlata, Mariavirginia Boni, Gianluca G Ianiro, Pierangelo Santori, Jan F Tack, Emidio Scarpellini
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73 (9) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Ege Tohumcu, Francesco Kaitsas, Ludovica Bricca, Alessandro Ruggeri, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
Helicobacter pylori and the Human Gastrointestinal Microbiota: A Multifaceted Relationship. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Giulia Catassi, Marina Aloi, Valentina Giorgio, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
The Role of Diet and Nutritional Interventions for the Infant Gut Microbiome. Nutrients 16 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Dan Linetzky Waitzberg, Francisco Guarner, Ivan Pavić, Gianluca G Ianiro, D Brent Polk, Harry Sokol
Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Advances in therapy 41 (3) (2024)
Lucia Boccabella, Elena Gialluca Palma, Ludovico Montebianco Abenavoli, Giuseppe Guido Maria Scarlata, Mariavirginia Boni, Gianluca G Ianiro, Pierangelo Santori, Jan F Tack, Emidio Scarpellini
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance. Antibiotics (Basel, Switzerland) 13 (3) (2024)
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73 (9) (2024)
Emilie E van Lingen, Simon Mark Dahl Jørgensen, Simone S C Lieberknecht, Nicolas N Benech, Gianluca G Ianiro, Harry H Sokol, Alessandro A Gasbarrini, Giovanni G Cammarota, Marcel M K Eriksen, Andrea A E van der Meulen-de Jong, Elizabeth E M Terveer, Hein H W Verspaget, Maria M Vehreschild, Christian C L Hvas, Josbert J J Keller
Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. Therapeutic advances in gastroenterology 16 (2023)
Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca G Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio Sanguinetti, Silvio Danese, Herbert Tilg, Fabio Cominelli, Theresa T Pizarro, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Severine Vermeire, Franco Scaldaferri
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut (2023)
Luigi Boccuto, Jan Tack, Gianluca G Ianiro, Ludovico Abenavoli, Emidio Scarpellini
Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. Genes 14 (4) (2023)
William Fusco, Manuel Bernabeu Lorenzo, Cintoni Marco, Serena Porcari, Emanuele Rinninella, Francesco Kaitsas, Elena Lener, Maria Cristina Mele, Antonio Gasbarrini, Maria Carmen Collado, Giovanni Cammarota, Gianluca G Ianiro
Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients 15 (9) (2023)
Massimo Montalto, Antonella Gallo, Maria Chiara Agnitelli, Simona Pellegrino, Alice Lipari, Erika Pero, Marcello Covino, Francesco Landi, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients. Journal of the American Geriatrics Society (2023)
Luigi Boccuto, Jan Tack, Gianluca G Ianiro, Ludovico Abenavoli, Emidio Scarpellini
Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. Genes 14 (4) (2023)
Carlo Airola, Andrea Severino, Serena Porcari, William Fusco, Benjamin Harvey Mullish, Antonio Gasbarrini, Giovanni Cammarota, Francesca Romana Ponziani, Gianluca G Ianiro
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Marcello Fiorani, Ege Tohumcu, Livio Enrico Del Vecchio, Serena Porcari, Giovanni Cammarota, Antonio Gasbarrini, Gianluca G Ianiro
The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Luigi Boccuto, Jan Tack, Gianluca G Ianiro, Ludovico Abenavoli, Emidio Scarpellini
Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. Genes 14 (4) (2023)
Luigi Boccuto, Jan Tack, Gianluca G Ianiro, Ludovico Abenavoli, Emidio Scarpellini
Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms. Genes 14 (4) (2023)
Remo Poto, Gianluca G Ianiro, Amato de Paulis, Giuseppe Spadaro, Giancarlo Marone, Antonio Gasbarrini, Gilda Varricchi
Is there a role for microbiome-based approach in common variable immunodeficiency? Clinical and experimental medicine (2023)
Remo Poto, Gianluca G Ianiro, Amato de Paulis, Giuseppe Spadaro, Giancarlo Marone, Antonio Gasbarrini, Gilda Varricchi
Is there a role for microbiome-based approach in common variable immunodeficiency? Clinical and experimental medicine (2023)
Remo Poto, Gianluca G Ianiro, Amato de Paulis, Giuseppe Spadaro, Giancarlo Marone, Antonio Gasbarrini, Gilda Varricchi
Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency? Clinical and experimental medicine (2023)
Marcello Fiorani, Ege Tohumcu, Livio Enrico Del Vecchio, Serena Porcari, Giovanni Cammarota, Antonio Gasbarrini, Gianluca G Ianiro
The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Remo Poto, Gianluca G Ianiro, Amato de Paulis, Giuseppe Spadaro, Giancarlo Marone, Antonio Gasbarrini, Gilda Varricchi
Is there a role for microbiome-based approach in common variable immunodeficiency? Clinical and experimental medicine (2023)
Emilie E van Lingen, Simon Mark Dahl Jørgensen, Simone S C Lieberknecht, Nicolas N Benech, Gianluca G Ianiro, Harry H Sokol, Alessandro A Gasbarrini, Giovanni G Cammarota, Marcel M K Eriksen, Andrea A E van der Meulen-de Jong, Elizabeth E M Terveer, Hein H W Verspaget, Maria M Vehreschild, Christian C L Hvas, Josbert J J Keller
Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. Therapeutic advances in gastroenterology 16 (2023)
Lucy Hocking, Gianluca G Ianiro, Rupert W L Leong, Tariq H Iqbal, Dina H Kao, Mark Cabling, Stephanie Stockwell, Robert J Romanelli, Sonja Marjanovic
Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems. Alimentary pharmacology & therapeutics (2022)
Alexis Mosca, Ana Teresa Abreu Y Abreu, Kok Ann Gwee, Gianluca G Ianiro, Tack Jan, Thi Viet Ha Nguyen, Colin Hill
The clinical evidence for postbiotics as microbial therapeutics. Gut microbes 14 (1) (2022)
Gianluca G Ianiro, Stefano Bibbò, Serena Porcari, Carlo Romano Settanni, Federica Giambò, Andreea Roxana Curta, Gianluca Quaranta, Franco Scaldaferri, Luca Masucci, Sanguinetti Maurizio, Antonio Gasbarrini, Giovanni Cammarota
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center. Gut microbes 13 (1) (2022)
Gianluca Quaranta, Gianluca G Ianiro, Flavio De Maio, Alessandra Guarnaccia, Giovanni Fancello, Chiara Agrillo, Federica Iannarelli, Stefano Bibbo, Amedeo Amedei, Sanguinetti Maurizio, Giovanni Cammarota, Luca Masucci
"Bacterial Consortium": A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection. BioMed research international 2022 (2022)
Maria Rosa Ingrosso, Gianluca G Ianiro, Judy W Nee, Anthony J Lembo, Paul Moayyedi, Christopher J Black, Alexander Charles Ford
Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply. Alimentary pharmacology & therapeutics 56 (7) (2022)
Lucy Hocking, Gianluca G Ianiro, Rupert W L Leong, Tariq H Iqbal, Dina H Kao, Mark Cabling, Stephanie Stockwell, Robert J Romanelli, Sonja Marjanovic
Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems. Alimentary pharmacology & therapeutics 57 (5) (2022)
Qin Liu, Giovanni Cammarota, Gianluca G Ianiro
Evaluating microbial determinants of donor efficacy to translate faecal microbiota transplantation from research to clinical practice. Gut (2022)
Maria Rosa Ingrosso, Gianluca G Ianiro, Judy W Nee, Anthony J Lembo, Paul Moayyedi, Christopher J Black, Alexander Charles Ford
Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary pharmacology & therapeutics 56 (6) (2022)
Lucy Hocking, Gianluca G Ianiro, Rupert W L Leong, Tariq H Iqbal, Dina H Kao, Mark Cabling, Stephanie Stockwell, Robert J Romanelli, Sonja Marjanovic
Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems. Alimentary pharmacology & therapeutics 57 (5) (2022)
Gianluca G Ianiro, Andrea Iorio, Serena Porcari, Luca Masucci, Maurizio Sanguinetti, Carlo Federico Perno, Antonio Gasbarrini, Lorenza Putignani, Giovanni Cammarota
How the gut parasitome affects human health. Therapeutic advances in gastroenterology 15 (2022)
Gianluca G Ianiro, Michal Punčochář, Nicolai Karcher, Serena Porcari, Federica Armanini, Francesco Asnicar, Francesco Beghini, Aitor Blanco-Míguez, Fabio Cumbo, Paolo Manghi, Federica Pinto, Luca Masucci, Gianluca Quaranta, Silvia De Giorgi, Giusi Desirè Sciumè, Stefano Bibbò, Federica Del Chierico, Lorenza Putignani, Sanguinetti Maurizio, Antonio Gasbarrini, Mireia Valles-Colomer, Giovanni Cammarota, Nicola Segata
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nature medicine 28 (9) (2022)
Martina De Siena, Lucrezia Laterza, Maria Valeria Matteo, Irene Mignini, Tommaso Schepis, Gianenrico Rizzatti, Gianluca G Ianiro, Emanuele Rinninella, Cintoni Marco, Antonio Gasbarrini
Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy. Microorganisms 9 (3) (2021)
Gianluca G Ianiro, Jonathan P Segal, Benjamin Harvey Mullish, Mohammed N Quraishi, Serena Porcari, Ginevra Fabiani, Antonio Gasbarrini, Giovanni Cammarota
Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future microbiology 15 (2021)
Gianluca G Ianiro, Henriette Heinrich
Kindhearted, determined firecracker: A tribute to Radislav Nakov. United European gastroenterology journal (2021)
Mirjana Rajilic-Stojanovic, Ceu Figueiredo, Annemieke Smet, Richard Hansen, Juozas Kupcinskas, Theo Rokkas, Leif Andersen, Jose C Machado, Gianluca G Ianiro, Antonio Gasbarrini, Marcis Leja, Francisco Javier García-Alonso, Georgina L Hold
Systematic review: gastric microbiota in health and disease. Alimentary pharmacology & therapeutics 51 (6) (2020)
Gianluca G Ianiro, Benjamin Harvey Mullish, Colleen R Kelly, Zain Kassam, Ed J Kuijper, William K K Wu, Tariq H Iqbal, Jessica R Allegretti, Stefano Bibbò, Harry Sokol, Faming Zhang, Monika Fischer, Samuel Paul Costello, Josbert J Keller, Luca Masucci, Joffrey van Prehn, Gianluca Quaranta, Mohammed Nabil Nabil Quraishi, Jonathan P Segal, Dina Kao, Reetta Satokari, Maurizio Sanguinetti, Herbert Tilg, Antonio Gasbarrini, Giovanni Cammarota
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 69 (9) (2020)
Maria Vittoria Ristori, Stefano Levi Mortera, Valeria Marzano, Silvia Guerrera, Pamela Vernocchi, Gianluca G Ianiro, Simone Gardini, Giuliano Torre, Giovanni Valeri, Stefano Vicari, Antonio Gasbarrini, Lorenza Putignani
Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery. International journal of molecular sciences 21 (17) (2020)
Emanuele Rinninella, Maria Cristina Mele, Cintoni Marco, Pauline Raoul, Gianluca G Ianiro, Lucia Salerno, Carmelo Pozzo, Emilio Bria, Maurizio Muscaritoli, Alessio Molfino, Antonio Gasbarrini
The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies. Nutrients 12 (8) (2020)
Gianluca G Ianiro, Serena Porcari, Alexander Charles Ford, Antonio Gasbarrini, Giovanni Cammarota
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Alimentary pharmacology & therapeutics 52 (5) (2020)
Francesca Romana Ponziani, Fabio Del Zompo, Antonio Nesci, Francesco Santopaolo, Gianluca G Ianiro, Maurizio Pompili, Antonio Gasbarrini, null null
Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients. Alimentary pharmacology & therapeutics 52 (6) (2020)
Gianluca G Ianiro, Ernesto Rossi, Andrew Maltez Thomas, Giovanni Schinzari, Luca Masucci, Gianluca Quaranta, Carlo Romano Settanni, Loris Riccardo Lopetuso, Federica Armanini, Aitor Blanco-Miguez, Francesco Asnicar, Clarissa Consolandi, Roberto Iacovelli, Sanguinetti Maurizio, Giampaolo Tortora, Antonio Gasbarrini, Nicola Segata, Giovanni Cammarota
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma. Nature communications 11 (1) (2020)
Giovanni Cammarota, Gianluca G Ianiro, Anna Ahern, Carmine Carbone, Andriy Temko, Marcus Joakim Claesson, Antonio Gasbarrini, Giampaolo Tortora
Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nature reviews. Gastroenterology & hepatology 17 (10) (2020)
Gianluca G Ianiro, Francesca Romana Ponziani, Antonio Gasbarrini, Giovanni Cammarota
Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism? Alimentary pharmacology & therapeutics 50 (4) (2020)
Emanuele Rinninella, Cintoni Marco, Pauline Raoul, Gianluca G Ianiro, Lucrezia Laterza, Loris Riccardo Lopetuso, Francesca Romana Ponziani, Antonio Gasbarrini, Maria Cristina Mele
Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases. Microorganisms 8 (8) (2020)
Stefano Bibbo, Carlo Romano Settanni, Serena Porcari, Enrico Bocchino, Gianluca G Ianiro, Giovanni Cammarota, Antonio Gasbarrini
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor. Journal of clinical medicine 9 (6) (2020)
Cicilia Marcella, Bota Cui, Colleen R Kelly, Gianluca G Ianiro, Giovanni Cammarota, Faming Zhang
Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Alimentary pharmacology & therapeutics 53 (1) (2020)
Gianluca G Ianiro, Antonio Gasbarrini, Giovanni Cammarota
Autologous faecal microbiota transplantation for type 1 diabetes: a potential mindshift in therapeutic microbiome manipulation? Gut 70 (1) (2020)
Gianluca G Ianiro, Leonardo Henry Umberto Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford
Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Alimentary pharmacology & therapeutics 50 (3) (2019)
Gianluca G Ianiro, L Masucci, G Quaranta, C Simonelli, Loris Riccardo Lopetuso, M Sanguinetti, A Gasbarrini, Giovanni Cammarota
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Alimentary pharmacology & therapeutics 48 (2) (2018)